Blueprint Medicines Cash Flow from Operating Activities 2014-2025 | BPMC
Blueprint Medicines cash flow from operating activities for the twelve months ending March 31, 2025 was $-0.560B, a 51.3% decline year-over-year.
- Blueprint Medicines annual cash flow from operating activities for 2024 was $-0.193B, a 55.91% decline from 2023.
- Blueprint Medicines annual cash flow from operating activities for 2023 was $-0.437B, a 13.03% decline from 2022.
- Blueprint Medicines annual cash flow from operating activities for 2022 was $-0.502B, a 68.18% increase from 2021.